In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Perrigo

This article was originally published in The Rose Sheet

Executive Summary

Perrigo: Sales for the private-label company rose 6% to $196.3 mil. in the third quarter (ended March 31). The company reported a 4% decline in personal care product sales, noting that that business "remains challenging." In an effort to restore profitably in its personal care segment, Perrigo has been eliminating low-volume SKUs and raising product prices to help counter increasing raw material cost over the past year. Net earnings for the company, including extraordinary costs of $263,000 for restructuring and $1.6 mil. for litigation, fell 6.9% to $10.6 mil...
UsernamePublicRestriction

Register

RS002826

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel